MAPT and Alzheimer disease: ,19,30,31 To further explore responses of astrocytes to pathological tau, we optimized a human cell-based assay for seeding with AD brain derived sarkosyl-insoluble tau aggregates, considering that synthetic tau fibrils, with their distinct conformational structure,20 might elicit different cellular responses.